Bank of New York Mellon’s Sutro Biopharma STRO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-209,222
| Closed | -$136K | – | 4239 |
|
2025
Q1 | $136K | Sell |
209,222
-8,405
| -4% | -$5.47K | ﹤0.01% | 3943 |
|
2024
Q4 | $400K | Buy |
217,627
+2,578
| +1% | +$4.74K | ﹤0.01% | 3611 |
|
2024
Q3 | $744K | Sell |
215,049
-57,670
| -21% | -$200K | ﹤0.01% | 3291 |
|
2024
Q2 | $799K | Buy |
272,719
+88,034
| +48% | +$258K | ﹤0.01% | 3315 |
|
2024
Q1 | $1.04M | Sell |
184,685
-77,939
| -30% | -$440K | ﹤0.01% | 3123 |
|
2023
Q4 | $1.13M | Buy |
262,624
+1,173
| +0.4% | +$5.03K | ﹤0.01% | 3125 |
|
2023
Q3 | $907K | Buy |
261,451
+8,633
| +3% | +$30K | ﹤0.01% | 3207 |
|
2023
Q2 | $1.18M | Buy |
252,818
+12,574
| +5% | +$58.5K | ﹤0.01% | 3105 |
|
2023
Q1 | $1.11M | Buy |
240,244
+1,539
| +0.6% | +$7.11K | ﹤0.01% | 3089 |
|
2022
Q4 | $1.93M | Buy |
238,705
+82,832
| +53% | +$669K | ﹤0.01% | 2871 |
|
2022
Q3 | $865K | Buy |
155,873
+18,890
| +14% | +$105K | ﹤0.01% | 3277 |
|
2022
Q2 | $714K | Sell |
136,983
-13,635
| -9% | -$71.1K | ﹤0.01% | 3372 |
|
2022
Q1 | $1.24M | Buy |
150,618
+1,003
| +0.7% | +$8.24K | ﹤0.01% | 3178 |
|
2021
Q4 | $2.23M | Sell |
149,615
-17,264
| -10% | -$257K | ﹤0.01% | 2930 |
|
2021
Q3 | $3.15M | Buy |
166,879
+13,283
| +9% | +$251K | ﹤0.01% | 2737 |
|
2021
Q2 | $2.86M | Buy |
153,596
+52,198
| +51% | +$971K | ﹤0.01% | 2777 |
|
2021
Q1 | $2.31M | Buy |
101,398
+583
| +0.6% | +$13.3K | ﹤0.01% | 2842 |
|
2020
Q4 | $2.19M | Buy |
100,815
+39,452
| +64% | +$857K | ﹤0.01% | 2794 |
|
2020
Q3 | $617K | Buy |
61,363
+11,458
| +23% | +$115K | ﹤0.01% | 3383 |
|
2020
Q2 | $387K | Buy |
49,905
+21,051
| +73% | +$163K | ﹤0.01% | 3594 |
|
2020
Q1 | $295K | Buy |
28,854
+16
| +0.1% | +$164 | ﹤0.01% | 3604 |
|
2019
Q4 | $317K | Hold |
28,838
| – | – | ﹤0.01% | 3780 |
|
2019
Q3 | $262K | Sell |
28,838
-1,634
| -5% | -$14.8K | ﹤0.01% | 3818 |
|
2019
Q2 | $347K | Buy |
30,472
+15,591
| +105% | +$178K | ﹤0.01% | 3751 |
|
2019
Q1 | $169K | Buy |
+14,881
| New | +$169K | ﹤0.01% | 3910 |
|